Thrombus Imaging and Treatment Analytics in Neurology
Launched by CHINESE PLA GENERAL HOSPITAL · Dec 15, 2022
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Thrombus Imaging and Treatment Analytics in Neurology" is investigating how detailed imaging of blood clots in the brain and neck can help understand the effectiveness of treatments aimed at removing these clots. Researchers are using advanced MRI technology to look closely at the structure of the blood vessels and the clots to see how different appearances of the clots might affect the success of the treatments.
To participate in this study, individuals must be at least 18 years old and have confirmed blockages in their brain or neck arteries. Participants will undergo specialized MRI scans to gather information about their condition. The trial is currently looking for volunteers, and it’s important to note that people with certain mild to moderate blockages, pregnant women, or those who have had specific recent procedures may not be eligible. If you join the study, you’ll be contributing to valuable research that could improve future treatments for similar conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years
- • Extracranial and/or intracranial artery occlusion confirmed by angiography
- • Available for magnetic resonance high-resolution vessel wall imaging
- • Written informed consent obtained
- Exclusion Criteria:
- • Extracranial and/or intracranial artery mild to moderate stenosis
- • Pregnant women
- • Restenosis or occlusion after artery stenting placement
About Chinese Pla General Hospital
The Chinese PLA General Hospital, a prominent military medical institution in Beijing, serves as a leading sponsor for clinical trials, focusing on advancing healthcare through innovative research and development. Renowned for its comprehensive medical services and cutting-edge research capabilities, the hospital is committed to improving patient outcomes through rigorous scientific investigation and collaboration with various stakeholders in the healthcare sector. With a multidisciplinary approach and a strong emphasis on evidence-based practices, the Chinese PLA General Hospital aims to contribute significantly to the global medical community by facilitating the development of safe and effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Beijing, Beijing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials